# Prevention of Bladder Dysfunction in Acute Spinal Cord Injury

> **NCT01698138** · PHASE4 · COMPLETED · sponsor: **Oslo University Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Spinal Cord Injuries
- Urinary Bladder, Overactive

## Interventions

- **DRUG:** Onabotulinumtoxin A
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01698138
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2020-12-20
- **Final completion:** 2020-12-20
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-11-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01698138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01698138, "Prevention of Bladder Dysfunction in Acute Spinal Cord Injury". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01698138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*